Fig. 1. A model to explain the pleiotropy of CEP290 disease.

Slides:

Advertisements

Similar presentations

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

Advertisements

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

Simplified view of the cellular RNA and protein quality surveillance or control systems. Stop-codon introductions as well as splice-site variations, resulting.

Simplified view of the cellular RNA and protein quality surveillance or control systems. Stop-codon introductions as well as splice-site variations, resulting.

Gene Mutations.

Forensic DNA Analysis Protein Synthesis.

Fine Mapping and Functional Analysis Reveal a Role of SLC22A1 in Acylcarnitine Transport Hye In Kim, Johannes Raffler, Wenyun Lu, Jung-Jin Lee, Deepti.

Regulated Unproductive Splicing

Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen Aα-chain gene are not associated with the decay of the mutant.

Strategy for CRISPR/Cas9-mediated genome editing in ΔEx50 mice

A: OAZ1 mRNA transcript of 775-1, and parental cell lines showing the stop codon introduced by the nonsense mutations in the and transcripts,

Group A1 Caroline Kissel, Meg Sabourin, Kaylee Isaacs, Alex Maeder

Relationship between Genotype and Phenotype

Volume 54, Issue 3, Pages (September 1998)

Nonsense Surveillance in Lymphocytes?

Capillary Malformation–Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 Mutations Iiro Eerola, Laurence M. Boon, John.

Fig. 1. Mutations in slpA confer Av-CD291.2 resistance.

Schematic depiction of the effect of different types of Duchenne muscular dystrophy (DMD)-causing mutations on the dystrophin transcript. Schematic depiction.

Mutation Notes.

Oligo#5 influences the ratio of the two serotonin 2C receptor isoforms and changes the localization of the full‐length receptor Oligo#5 influences the.

Figure 2 Ribosome profiling reveals translation of truncating alleles

Fig. 7 Correlation of NHP and human ISGs.

Fig. 1 Movement percepts for all participants.

Fig. 1. Distribution of TTNtv in healthy individuals and DCM patients, and TTN exon usage in the heart. Distribution of TTNtv in healthy individuals and.

Fig. 3. The effect of VRC01 infusion on virus load in plasma and blood CD4 T cells during ART. The effect of VRC01 infusion on virus load in plasma and.

Multiple-exon skipping.

Volume 53, Issue 5, Pages (May 1998)

Consolidated Standards of Reporting Trials flow diagram of VRC trial

Fig. 1. Loss of circadian rhythms in iKO mice.

Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.

Fig. 5. Microarray analysis of tumors treated by dabrafenib, trametinib, or the combination of dabrafenib and trametinib with pmel-1 ACT or mock ACT. Microarray.

Fig. 1. Schematic showing the shedding of tumor DNA from head and neck cancers into the saliva or plasma. Schematic showing the shedding of tumor DNA from.

Fig. 3. Comparison of prediction performance.

SMN1 and SMN2 contribute to spinal muscular atrophy (SMA).

Fig. 6. TIV-09, but not MIV-09, induces an IFN signature in the blood of vaccinated individuals at day 1. TIV-09, but not MIV-09, induces an IFN signature.

Arun Kumar, Satish C. Girimaji, Mahesh R. Duvvari, Susan H. Blanton

Fig. 2 Overview of transcriptional mutagenesis in yeast.

Fig. 3 Conditionally expressed CAR using Notch as a signal induction and response pathway system. Conditionally expressed CAR using Notch as a signal induction.

Fig. 4 p100/TSN enables E2F1 to interact with alternatively spliced transcripts. p100/TSN enables E2F1 to interact with alternatively spliced transcripts.

Fig. 3. BET inhibition reduces homologous recombination.

Fig. 5 E2F1 also interacts with alternatively spliced transcripts from the MECOM gene. E2F1 also interacts with alternatively spliced transcripts from.

Fig. 5. In vivo characterization of adipogenesis by CT.

Fig. 2. Bacterial/viral score in COCONUT-conormalized whole-blood validation data sets. Bacterial/viral score in COCONUT-conormalized whole-blood validation.

Fig. 5. Vitamin B12 supplementation in the host altered the transcriptome of P. acnes in the skin microbiota. Vitamin B12 supplementation in the host altered.

Fig. 1. Detection of circulating tumor DNA in CRPC patients.

Figure Unique second neurofibromatosis type 1 (NF1) gene mutations in multiple café-au-lait macules (CALMs) from an individual with segmental NF1 Unique.

Fig. 4. Long-term persistence of CTL019 cells and polyfunctionality in patients achieving CR. Long-term persistence of CTL019 cells and polyfunctionality.

Structure of the IFL1 Gene and the Nature of the Mutations in the ifl1 Alleles.(A) A schematic representation of the exon and intron organization of the.

The microchip-based drug delivery device and overview of study design

Fig. 2 Cas9/RecA-mediated in vivo gene correction of Pde6b.

Fig. 2. Mutational signature exposures in Taiwan HCCs and summary of AA signature mutations. Mutational signature exposures in Taiwan HCCs and summary.

Fig. 2 PK dosing results. PK dosing results. (A) Plasma concentration of hPTH(1–34) versus time after release of 40-μg dose from implanted microchip device.

Illustration of working hypothesis and biological impact of retained introns. Illustration of working hypothesis and biological impact of retained introns.

Fig. 1 Exon 44–deleted DMD patient iPSC-derived cardiomyocytes express dystrophin after CRISPR-Cas9–mediated genome editing. Exon 44–deleted DMD patient.

Representative CT and PET/CT images of three patients with NSCLCs

Fig. 1 Crohn’s disease association within the LRRK2 locus.

Depicting brighter possibilities for treating blindness

Fig. 5. Vascularization of human liver seed grafts.

Delineating cancer evolution with single-cell sequencing

Fig. 1. Frequency of reportedly pathogenic PRNP variants: >30 times higher in controls than expected on the basis of disease incidence. Frequency of reportedly.

Fig. 1 Relevance of therapies for treating retinal degeneration and stage of disease. Relevance of therapies for treating retinal degeneration and stage.

Fig. 5. High burdens of AA signature mutations and predicted immunogenicity in Taiwan HCCs. High burdens of AA signature mutations and predicted immunogenicity.

Fig. 3. Association between peak CTL019 expansion and response.

Fig. 1. Schematic description of whole-exome or targeted next-generation sequencing analyses. Schematic description of whole-exome or targeted next-generation.

BRCA1 protein functional domains and predicted frameshift and premature truncation. BRCA1 protein functional domains and predicted frameshift and premature.

Fig. 2 DMD iPSC-derived cardiomyocytes express dystrophin after Cpf1-mediated genome editing by reframing. DMD iPSC-derived cardiomyocytes express dystrophin.

Fig. 8 Immune correlates of protection.

Fig. 3 Postnatal assembly of the humanized gut microbiota.

Fig. 1 Anti-LtxA antibody concentrations in various patient groups.

Presentation transcript:

Fig. 1. A model to explain the pleiotropy of CEP290 disease. A model to explain the pleiotropy of CEP290 disease. (A) A schematic of nonsense-induced alternative splicing. (I and III) A gene transcript containing a nonsense mutation (red line) undergoes canonical splicing. In both cases, the inclusion of the exon harboring the nonsense mutation targets the transcript for nonsense-mediated decay. (II) Alternative splicing yields a transcript lacking exon 2 and the premature stop codon. The message persists and results in a truncated but otherwise intact open reading frame. (IV) Alternative splicing yields a transcript lacking exon 3 and the premature stop codon but containing a frameshift from the splicing together of incompatible exon ends, resulting in nonsense-mediated decay. (B) A model for predicting CEP290 protein production in individual patients for whom both CEP290 disease alleles are known (fig. S1). Listed below the model are the CEP290 disease phenotypes predicted to be associated with each protein amount. Theodore G. Drivas et al., Sci Transl Med 2015;7:291ra97 Copyright © 2015, American Association for the Advancement of Science